Camtek Ltd. filings document foreign-issuer current reports on operating results, customer orders, investor presentations, material agreements, capital structure and governance. The company’s Form 6-K disclosures include financial-result releases, order announcements for semiconductor inspection and metrology systems, and operating and financial review materials.
Camtek’s regulatory record also covers capital-structure activity, including convertible senior notes due 2030, and risk disclosures tied to semiconductor capital spending, demand for HPC, HBM and chiplet devices, global trade and export restrictions, and geographic concentration in Asia Pacific markets. These filings describe the company as a Nasdaq- and TASE-listed supplier serving IDMs, OSATs and foundries.
Camtek Ltd (CAMT) submitted a Form 144 notice reporting a proposed sale of 21,321 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,844,906.13. The sale is scheduled approximately for 08/13/2025 and the shares are listed on Nasdaq. The form states the issuer has 45,449,306 shares outstanding, providing context for the transaction size.
The securities to be sold were acquired as restricted stock units from the issuer on 04/28/2021 (2,774 shares), 01/24/2022 (4,637 shares), and 01/16/2023 (13,910 shares), which together equal the 21,321 shares offered. The filing reports no securities sold in the past three months and includes the seller's standard representation that they are unaware of any undisclosed material adverse information; a trading-plan reference is noted but no plan adoption date is provided.
Camtek Ltd (CAMT) Form 144 filing discloses that an unidentified insider intends to sell 7,300 ordinary shares through broker Oppenheimer & Co. The planned transaction, scheduled on or about 08-07-2025, carries an aggregate market value of $594,147, based on the prevailing market price when the notice was prepared.
The shares represent roughly 0.016 % of Camtek’s 45.45 million shares outstanding, implying a modest dilution impact. The stock to be sold derives from previously granted restricted stock units (RSUs) acquired on 09-24-2020 (6,500 shares) and 08-18-2021 (800 shares). No shares were sold by the filer in the past three months, and the signer affirms possession of no undisclosed material adverse information.
While the filing is routine and compliant with Rule 144, it signals a limited insider disposition that investors may interpret as a marginally negative sentiment check rather than a material event for the company’s fundamentals.